# Abpro Holdings, Inc.: financial statements, quarterly

ABPO · OTC · CIK 1893219 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/abpo.md) · [Financials](/companies/abpo/financials.md) · [Filings](/companies/abpo/filings.md) · [Insiders](/companies/abpo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/abpo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Research and development | $m | not reported | not reported | [1.0](/filings/0001213900-25-044318.md) | [0.8](/filings/0001213900-25-075691.md) | [0.6](/filings/0001213900-25-110972.md) | [0.5 d](/filings/0001213900-26-044166.md) | [0.3](/filings/0001213900-26-059646.md) | [0.3](/filings/0001213900-26-090028.md) | [0.2](/filings/0001213900-25-110972.md) | [0.1 d](/filings/0001213900-26-044166.md) | [0.0](/filings/0001213900-26-059646.md) | [0.0](/filings/0001213900-26-090028.md) |
| Operating income | $m | [(0.3)](/filings/0001213900-24-102370.md) | [(10.5) d](/filings/0001213900-25-032133.md) | [(2.9)](/filings/0001213900-25-044318.md) | [(2.3)](/filings/0001213900-25-075691.md) | [(1.9)](/filings/0001213900-25-110972.md) | [(2.8) d](/filings/0001213900-26-044166.md) | [(3.0)](/filings/0001213900-26-059646.md) | [(2.3)](/filings/0001213900-26-090028.md) | [(1.3)](/filings/0001213900-25-110972.md) | [(1.9) d](/filings/0001213900-26-044166.md) | [(0.9)](/filings/0001213900-26-059646.md) | [(1.2)](/filings/0001213900-26-090028.md) |
| Interest expense | $m | [0.1](/filings/0001213900-24-102370.md) | [(0.1) d](/filings/0001213900-25-032133.md) | [0.0](/filings/0001213900-25-044318.md) | [0.1](/filings/0001213900-25-075691.md) | [0.2](/filings/0001213900-25-110972.md) | [0.1 d](/filings/0001213900-26-044166.md) | [0.7](/filings/0001213900-26-059646.md) | [0.2](/filings/0001213900-26-090028.md) | [0.2](/filings/0001213900-25-110972.md) | [0.0 d](/filings/0001213900-26-044166.md) | [0.0](/filings/0001213900-26-059646.md) | [0.0](/filings/0001213900-26-090028.md) |
| Income tax | $m | [0.1](/filings/0001213900-24-102370.md) | [0.1 d](/filings/0001193125-24-082201.md) | [0.0](/filings/0001193125-24-176812.md) | [0.0](/filings/0001193125-24-206165.md) | [0.0](/filings/0001213900-24-102370.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(0.0)](/filings/0001213900-24-102370.md) | [(0.0) d](/filings/0001193125-24-082201.md) | [0.3](/filings/0001213900-25-044318.md) | [(0.3)](/filings/0001213900-24-102370.md) | [(0.3)](/filings/0001213900-24-102370.md) | [(5.5) d](/filings/0001213900-26-044166.md) | [(3.9)](/filings/0001213900-25-044318.md) | [(3.0)](/filings/0001213900-26-090028.md) | [(1.7)](/filings/0001213900-25-110972.md) | [5.6 d](/filings/0001213900-26-044166.md) | [(1.0)](/filings/0001213900-26-090028.md) | [(0.9)](/filings/0001213900-26-090028.md) |
| Diluted EPS | $ per share | not reported | not reported | [0.01](/filings/0001213900-25-044318.md) | [(0.13)](/filings/0001213900-25-075691.md) | [(3.27)](/filings/0001213900-25-110972.md) | not reported | [(2.29)](/filings/0001213900-26-059646.md) | [(1.56)](/filings/0001213900-26-090028.md) | [(0.63)](/filings/0001213900-25-110972.md) | not reported | [(0.23)](/filings/0001213900-26-059646.md) | [(0.16)](/filings/0001213900-26-090028.md) |
| Basic EPS | $ per share | not reported | not reported | [0.02](/filings/0001213900-25-044318.md) | [(0.13)](/filings/0001213900-25-075691.md) | [(3.27)](/filings/0001213900-25-110972.md) | not reported | [(2.29)](/filings/0001213900-26-059646.md) | [(1.56)](/filings/0001213900-26-090028.md) | [(0.63)](/filings/0001213900-25-110972.md) | not reported | [(0.23)](/filings/0001213900-26-059646.md) | [(0.16)](/filings/0001213900-26-090028.md) |

- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.9](/filings/0001193125-23-296620.md) | [0.7](/filings/0001213900-25-032133.md) | [0.0](/filings/0001193125-24-176812.md) | [0.2](/filings/0001193125-24-206165.md) | [0.0](/filings/0001213900-24-102370.md) | [2.9](/filings/0001213900-25-032133.md) | [1.3](/filings/0001213900-26-059646.md) | [2.0](/filings/0001213900-26-090028.md) | [0.3](/filings/0001213900-25-110972.md) | [0.1](/filings/0001213900-26-090028.md) | [5.4](/filings/0001213900-26-059646.md) | [4.2](/filings/0001213900-26-090028.md) |
| Current assets | $m | [1.1](/filings/0001193125-23-296620.md) | [2.0](/filings/0001213900-25-032133.md) | [0.0](/filings/0001193125-24-176812.md) | [0.3](/filings/0001193125-24-206165.md) | [1.6](/filings/0001213900-24-102370.md) | [3.8](/filings/0001213900-26-044166.md) | [2.2](/filings/0001213900-25-044318.md) | [3.1](/filings/0001213900-25-075691.md) | [1.2](/filings/0001213900-25-110972.md) | [0.9](/filings/0001213900-26-090028.md) | [6.7](/filings/0001213900-26-059646.md) | [5.1](/filings/0001213900-26-090028.md) |
| Total assets | $m | [37.5](/filings/0001193125-23-296620.md) | [3.4](/filings/0001213900-25-032133.md) | [7.5](/filings/0001193125-24-176812.md) | [7.9](/filings/0001193125-24-206165.md) | [7.9](/filings/0001213900-24-102370.md) | [4.7](/filings/0001213900-26-044166.md) | [2.8](/filings/0001213900-25-044318.md) | [3.5](/filings/0001213900-25-075691.md) | [1.7](/filings/0001213900-25-110972.md) | [1.1](/filings/0001213900-26-090028.md) | [6.9](/filings/0001213900-26-059646.md) | [5.2](/filings/0001213900-26-090028.md) |
| Current liabilities | $m | [5.5](/filings/0001193125-23-296620.md) | [15.7](/filings/0001213900-25-032133.md) | [6.6](/filings/0001193125-24-176812.md) | [7.3](/filings/0001193125-24-206165.md) | [9.0](/filings/0001213900-24-102370.md) | [19.6](/filings/0001213900-26-044166.md) | [20.6](/filings/0001213900-25-044318.md) | [20.4](/filings/0001213900-25-075691.md) | [17.3](/filings/0001213900-25-110972.md) | [9.3](/filings/0001213900-26-090028.md) | [9.1](/filings/0001213900-26-059646.md) | [8.2](/filings/0001213900-26-090028.md) |
| Total liabilities | $m | [16.0](/filings/0001193125-23-296620.md) | [16.2](/filings/0001213900-25-032133.md) | [17.1](/filings/0001193125-24-176812.md) | [17.8](/filings/0001193125-24-206165.md) | [18.6](/filings/0001213900-25-032133.md) | [19.6](/filings/0001213900-25-032133.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(15.1)](/filings/0001213900-24-102370.md) | [(89.0)](/filings/0001213900-25-032133.md) | [(17.0)](/filings/0001213900-24-102370.md) | [(17.4)](/filings/0001213900-24-102370.md) | [(17.8)](/filings/0001213900-24-102370.md) | [(15.5)](/filings/0001213900-26-044166.md) | [(18.4)](/filings/0001213900-25-044318.md) | [(17.5)](/filings/0001213900-25-075691.md) | [(16.1)](/filings/0001213900-25-110972.md) | [(8.8)](/filings/0001213900-26-090028.md) | [(2.8)](/filings/0001213900-26-059646.md) | [(3.5)](/filings/0001213900-26-090028.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(1.3) d](/filings/0001213900-24-102370.md) | [(5.9) d](/filings/0001213900-25-032133.md) | [(2.8)](/filings/0001213900-25-044318.md) | [(1.4) d](/filings/0001213900-25-075691.md) | [(1.0) d](/filings/0001213900-25-110972.md) | [(3.8) d](/filings/0001213900-26-044166.md) | [(1.5)](/filings/0001213900-26-059646.md) | [(1.0) d](/filings/0001213900-26-090028.md) | [(2.8) d](/filings/0001213900-25-110972.md) | [(0.6) d](/filings/0001213900-26-044166.md) | [(2.1)](/filings/0001213900-26-059646.md) | [(1.1) d](/filings/0001213900-26-090028.md) |
| Share repurchases | $m | [0.0 d](/filings/0001213900-24-102370.md) | [0.0 d](/filings/0001193125-24-082201.md) | [29.7](/filings/0001193125-24-176812.md) | [0.0 d](/filings/0001193125-24-206165.md) | [0.0 d](/filings/0001213900-24-102370.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [44.5](/filings/0001213900-25-044318.md) | [19.2](/filings/0001213900-25-075691.md) | [0.6](/filings/0001213900-25-110972.md) | [1.7](/filings/0001213900-26-059646.md) | [1.9](/filings/0001213900-26-090028.md) | [2.6](/filings/0001213900-25-110972.md) | [4.5](/filings/0001213900-26-059646.md) | [5.9](/filings/0001213900-26-090028.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,896,048 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001213900-26-090028.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.